Envestnet Asset Management’s Intersect ENT, Inc XENT Stock Holding History

Envestnet Asset Management’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-7,542	Closed	-$242K	–	3105
2019 Q1	$242K	Buy	+7,542	New	+$233K	﹤0.01%	2741
2018 Q3	–	Sell	-56	Closed	-$2K	–	2852
2018 Q2	$2K	Hold	56	–	–	﹤0.01%	2768
2018 Q1	$2K	Hold	56	–	–	﹤0.01%	2740
2017 Q4	$2K	Hold	56	–	–	﹤0.01%	2877
2017 Q3	$2K	Sell	56 -186	-77%	-$5.5K	﹤0.01%	2827
2017 Q2	$7K	Buy	242 +186	+332%	+$4.21K	﹤0.01%	2786
2017 Q1	$1K	Hold	56	–	–	﹤0.01%	3083
2016 Q4	$1K	Buy	+56	New	+$725	﹤0.01%	3067
2016 Q2	–	Sell	-3,678	Closed	-$70K	–	3156
2016 Q1	$70K	Buy	+3,678	New	+$66.6K	﹤0.01%	2578

Other funds holding XENT

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Envestnet Asset Management's XENT Position: Q2 2019 in Review

Envestnet Asset Management sold out of Intersect ENT, Inc (XENT) in Q2 2019, closing a stake of 7,542 shares — an estimated $242K sold.

Envestnet Asset Management first reported a position in XENT in Q1 2016 and held it in 9 quarters. The position peaked at $242K in Q1 2019. 112 funds tracked by Wall St. Rank hold XENT as of Q2 2019.

Envestnet Asset Management reported no remaining Intersect ENT, Inc position as of Q2 2019 after selling out during the quarter.
Envestnet Asset Management sold 7,542 Intersect ENT, Inc shares in Q2 2019, an estimated $242K.
Envestnet Asset Management first reported a position in Intersect ENT, Inc in Q1 2016 and held it in 9 quarters.
Envestnet Asset Management's Intersect ENT, Inc position peaked at $242K in Q1 2019.
112 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2019.

Based on Envestnet Asset Management's 13F filing for Q2 2019, filed 2 Aug 2019.